IQVIA’s Middle East & Africa Pharmaceutical Business Insights Report – Fortieth Edition highlights strong pharmaceutical market growth across the region, reaching $42.43 billion in value sales and 9.3 billion units by MAT Q1 2026. The MEA market grew 11.2% year-over-year in value and 4.5% in volume, driven by retail expansion, hospital channel growth, and increased contributions from local companies. Retail remained the dominant channel with 67.7% value share, while multinational corporations maintained leadership with 54.9% market share. Saudi Arabia led the region with $15.35 billion in sales, followed by the UAE at $5.56 billion, which recorded the fastest growth at 17.1%. Key growth areas included Alimentary Tract & Metabolism, while companies such as Hikma, Novartis, Sanofi, and GSK r

Join for free to read